FIC 2026 closes: innovation, global reach and new category opportunities

The three-day FIC 2026, the 29th China International Food Additives and Ingredients Exhibition, closed at the National Exhibition and Convention Center in Shanghai. Asia's largest food-ingredients event sketched out the development blueprint for the global healthy-food industry.

Taiyi Health exhibited under the theme "Herbal origins, nutritional choice", presenting its core results in dual-channel enablement, customised CDMO services and cross-category innovation, combining Eastern herbal roots with advanced science to explore new opportunities in the health industry with partners from around the world.

Anchoring on advanced ingredients to achieve product differentiation

The health industry is shifting from general wellness to precise function. Traditional herbs have become a consumer staple for their safety and natural origin, while advanced functional ingredients keep driving the market upmarket. Modernising traditional herbs and localising advanced ingredients has become the core logic for breaking through, and demand is surging in segments such as weight management, skin management and sleep management.

In step with this upgrade, Taiyi Health's DIMT® digital co-decoction platform delivers standardised, efficient manufacturing of traditional herbs, producing a series of herbal essence drinks across nine functional directions including spleen support, dampness relief and qi-and-blood, bringing Chinese wellness into everyday consumption. In parallel, the company localises advanced ingredients popular overseas, including PHosGen™ NAD+ Pro, EquoYouth® S-equol, BeFisetin® fisetin and StanYouth® urolithin A, and combines them with classic food-and-medicine homology ingredients such as ginseng and Disugar® mulberry leaf extract to build evidence-based formulation systems that precisely match core segments such as weight management and anti-ageing beauty, giving customers a full-service solution from ingredient development to finished product.

Riding the cross-border trend with a supply chain built for efficient global expansion

As the health industry globalises, cross-border trade has become a new growth frontier, but overseas markets impose strict requirements on product certification, clean labels and ingredient standards; channel compliance and product localisation have become the core barriers for companies expanding abroad.

Taiyi Health has built a dual-channel supply enablement system covering both the domestic and cross-border markets. Domestically, it focuses on core high-demand segments with standardised, occasion-based products that help customers quickly capture private-domain and e-commerce channels. For cross-border business it offers a professional overseas CDMO solution, has secured the certifications overseas markets require, matches the clean-label demands for 100% plant origin and no artificial additives, and offers compliant ingredients and custom formulations such as SafDemo® saffron extract and Disugar® mulberry leaf extract, bridging domestic R&D strengths and overseas channel needs to help partners win share in the global nutrition market.

Focusing on ingestible–topical synergy to unlock new categories

The boundaries between food, beauty and health continue to dissolve; integrated ingestible-and-topical efficacy has become the mainstream of innovation, and consumer demand for health and beauty is moving from single categories to whole-scenario solutions. Companies need to step outside traditional category limits and use technological innovation to drive cross-category integration and sustained differentiation.

Guided by the principle of continuous innovation and breaking category boundaries, Taiyi Health is opening new business lines built on technology to create fresh growth curves for customers. In cosmetics and microneedle products it launched the CR3 patented multi-component cellular anti-ageing solution, precisely addressing the three core needs of anti-inflammation, antioxidation and anti-ageing and creating efficacy synergy between health foods and beauty products. It also unveiled a globally original silk-fibroin microneedle patch, forming a whole-scenario health solution that combines internal conditioning with external skin renewal, a highlight of cross-category innovation at the show.

The close of FIC 2026 marked the end of an industry exchange and a new starting point for Taiyi Health's deeper innovation and global connections. Beyond showing the industry its results in modernising Eastern herbs, the company reached cooperation intentions with many partners at home and abroad, laying a solid foundation for its global market expansion and the launch of new product innovations.